These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
500 related articles for article (PubMed ID: 33676349)
1. On the road to ending the COVID-19 pandemic: Are we there yet? Case JB; Winkler ES; Errico JM; Diamond MS Virology; 2021 May; 557():70-85. PubMed ID: 33676349 [TBL] [Abstract][Full Text] [Related]
2. Severe acute respiratory syndrome-coronavirus-2 spike (S) protein based vaccine candidates: State of the art and future prospects. Arashkia A; Jalilvand S; Mohajel N; Afchangi A; Azadmanesh K; Salehi-Vaziri M; Fazlalipour M; Pouriayevali MH; Jalali T; Mousavi Nasab SD; Roohvand F; Shoja Z; Rev Med Virol; 2021 May; 31(3):e2183. PubMed ID: 33594794 [TBL] [Abstract][Full Text] [Related]
3. COVID-19 Vaccine: A comprehensive status report. Kaur SP; Gupta V Virus Res; 2020 Oct; 288():198114. PubMed ID: 32800805 [TBL] [Abstract][Full Text] [Related]
4. New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates. Ura T; Yamashita A; Mizuki N; Okuda K; Shimada M Vaccine; 2021 Jan; 39(2):197-201. PubMed ID: 33279318 [TBL] [Abstract][Full Text] [Related]
5. Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development. Samrat SK; Tharappel AM; Li Z; Li H Virus Res; 2020 Oct; 288():198141. PubMed ID: 32846196 [TBL] [Abstract][Full Text] [Related]
6. Immunological considerations for COVID-19 vaccine strategies. Jeyanathan M; Afkhami S; Smaill F; Miller MS; Lichty BD; Xing Z Nat Rev Immunol; 2020 Oct; 20(10):615-632. PubMed ID: 32887954 [TBL] [Abstract][Full Text] [Related]
7. A systematic review of SARS-CoV-2 vaccine candidates. Dong Y; Dai T; Wei Y; Zhang L; Zheng M; Zhou F Signal Transduct Target Ther; 2020 Oct; 5(1):237. PubMed ID: 33051445 [TBL] [Abstract][Full Text] [Related]
13. Multivalent nanoparticle-based vaccines protect hamsters against SARS-CoV-2 after a single immunization. Chiba S; Frey SJ; Halfmann PJ; Kuroda M; Maemura T; Yang JE; Wright ER; Kawaoka Y; Kane RS Commun Biol; 2021 May; 4(1):597. PubMed ID: 34011948 [TBL] [Abstract][Full Text] [Related]
14. Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development? Lu L; Zhang H; Zhan M; Jiang J; Yin H; Dauphars DJ; Li SY; Li Y; He YW Sci China Life Sci; 2020 Dec; 63(12):1833-1849. PubMed ID: 33355886 [TBL] [Abstract][Full Text] [Related]
15. Construction and immunogenicity of SARS-CoV-2 virus-like particle expressed by recombinant baculovirus BacMam. Nguyen HT; Falzarano D; Gerdts V; Liu Q Microbiol Spectr; 2024 Aug; 12(8):e0095924. PubMed ID: 38916311 [TBL] [Abstract][Full Text] [Related]